Ursodeoxycholic acid for the treatment of hepatic sarcoid: A pre-post pilot study.

Clin Exp Hepatol · 2024 · PMC11650808 · PMID 39697366

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Results There was a decrease in ALP and GGT after six months of UDCA treatment compared to six months of observation (ALP – 257.6 to 202.2, p = 0.23; GGT – 302.5 to 111.8, p = 0.059), but this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.